Impact of B Cell Depletion on COVID-19 in Kidney Transplant Recipients

Kidney transplant recipients are patients at high risk for coronavirus disease 2019 (COVID-19) due to being on immunosuppressive therapy. B cell depletion therapy, including rituximab, is an important strategy for ABO-incompatible transplants. However, knowledge about the effect of B cell depletion...

Descripción completa

Detalles Bibliográficos
Autores principales: Aida, Naohiro, Ito, Taihei, Kurihara, Kei, Hiratsuka, Izumi, Shibata, Megumi, Suzuki, Atsushi, Hasegawa, Midori, Kenmochi, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385485/
https://www.ncbi.nlm.nih.gov/pubmed/37515206
http://dx.doi.org/10.3390/v15071520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385485/
https://www.ncbi.nlm.nih.gov/pubmed/37515206
http://dx.doi.org/10.3390/v15071520

Ejemplares similares